Spotlight On… Alan Thomson
director of diagnostics development AT MIP DIAGNOSTICS
Alan leads our diagnostic development work, with a focus on the in house licensing projects and is our Spotlight On employee this month.
Recent sample results for some in-house nanoMIPs produced against a small (circa 800MW) molecule template using Malvern Nanosight 300 - demonstrating good control over nanoMIP particle size, with very few nanoMIPs bigger or stuck together.
Read the latest news and updates from MIP Diagnostics in our March newsletter.
MIP Diagnostics expand patent portfolio as part of their impressive growth plan
MIP Diagnostics Ltd today announces the grant of a patent for the Preparation of Molecularly Imprinted Polymers by the United States Patent and Trademark Office (USPTO).
Spotlight On… Dr Joanna Czulak
Introducing another member of our talented team in our Spotlight On feature. This month meet Dr Joanna Czulak.
Using smart nanopolymers to kill old cells
NanoMIPs developed by MIP Diagnostics in collaboration with the University of Leicester have demonstrated their ability to target senescent cells, both in vitro and vivo. Such nanoMIPs were made to recognise one of the proteins abundant in on the surface of old cells and then tagged with a fluorescent molecule to aid in their detection. Also, these nanoMIPs were loaded with senolytic drugs and were able to selectively kill senescent cells.
Most Innovative Biotechnology Firm
We are so pleased to have been awarded 2019's Most Innovative Biotechnology Firm - United Kingdom by CV Magazine's Corporate Excellence Awards!
Read the latest news and updates from MIP Diagnostics in our February newsletter.
Article published in Chemical Communications
NanoMIPs to fight bacterial infection in the world of decreasing effectiveness of antibiotics
Spotlight On - Dr Andy Lakey
senior scientist at MIP diagnostics
Find out more about our exceptional team, in our Spotlight On feature. This month meet Dr Andy Lakey.
MIP Diagnostics Spotted at SLAS2019
9 TOP TECHNOLOGIES FROM THE EXHIBITION FLOOR
SelectScience editors reflect on the most exciting technologies showcased at the 2019 Society for Laboratory Automation and Screening conference and we are mentioned for our new Epitope Mapping Service.
MIPs in Space!
MIPs go Stratospheric!
A visit to the stratosphere demonstrates the exceptional robustness of MIPs which retain their function on return to earth. This was debuted at our Seminar in September 2018.
Paper published in ChemNanoMat
A Novel Assay Format as an Alternative to ELISA: MINA Test for Biotin – Is a published paper in ChemNanoMat with contributions made by Joanna Czulak of MIP Diagnostics, alongside colleagues at The University of Leicester and Imperial College London.
Paper published in the Journal of Advanced Materials Society
Novel assay format for proteins based on magnetic molecularly imprinted polymer nanoparticles—detection of pepsin is a published paper in the Journal of Chinese Advanced Materials Society, with contributions made by Joanna Czulak, Antonio Guerreiro and Francesco Canfarotta from MIP Diagnostics, alongside colleagues at The University of Leicester.
MIP Diagnostics Seminar
Join us for a day of presentations, networking, and discussions with key opinion leaders in the field of imprinted polymers and sensors.
OBN Awards Nomination
MIP Diagnostics are proud to be shortlisted as finalists at the OBN Awards in October.
Andy Lakey Joins as Senior Scientist
Dr Andrew Lakey brings his experience of developing point of care immunodiagnostics platforms to MIP Diagnostics, as a Senior Scientist.
New MIP Diagnostics Marketing Material
MIP Diagnostics have produced a new flyer featuring MIP technology and applications.
New Director of Diagnostics Development
MIP Diagnostics Ltd is pleased to announce that Alan Thomson has joined the company to lead the diagnostics development work.
Move to Colworth Park
MIP Diagnostics Ltd has moved from the founding laboratory at the University of Leicester, to new labs and offices at Colworth Park in Sharnbrook, Bedfordshire.
MIP New Investment
A Midlands-based life sciences company which develops ‘plastic antibodies’ has closed a £1.5m Series A funding round supported by Mercia Fund Managers and a number of private investors.
Jim Reid Appointed Chairman
To further support its plans for expansion, MIP Diagnostics has appointed Jim Reid as chair to provide valuable commercial expertise.